Madrigal MGL-3196-14 "A 52-Week Phase 3 Study of Resmetirom (MGL-3196)
Research Grant
Administered By
Radiology, Abdominal Imaging
Awarded By
Diabetes & Endocrinology Consultants, PC
Start Date
January 17, 2020
End Date
January 31, 2025
Administered By
Radiology, Abdominal Imaging
Awarded By
Diabetes & Endocrinology Consultants, PC
Start Date
January 17, 2020
End Date
January 31, 2025